| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | carbohydrate binding | GALNT16 NOMO2 P3H1 PKD1 PYGM ALDOA P3H3 SI NOMO1 GALNT5 ENG NOMO3 GALNT4 | 6.70e-05 | 310 | 230 | 13 | GO:0030246 |
| Domain | CarboxyPept-like_regulatory | 1.33e-06 | 17 | 225 | 5 | IPR008969 | |
| Domain | DUF2012 | 6.84e-06 | 4 | 225 | 3 | PF09430 | |
| Domain | DUF2012 | 6.84e-06 | 4 | 225 | 3 | IPR019008 | |
| Domain | Carb-bd-like_fold | 9.24e-05 | 8 | 225 | 3 | IPR013784 | |
| Pubmed | AFTPH MAP3K20 NOL10 BCOR NDUFS3 WDR75 SGPL1 USP7 OSBPL8 HELZ GNA11 ASCC3 CAMSAP2 EP400 LAMA5 FARSB INO80 SERPINH1 CYFIP2 TEFM NOMO1 CASK TAF6L CCNH ORMDL1 SLC25A1 EXD2 HLTF INTS9 USP6NL AQR HDLBP | 9.26e-09 | 1497 | 235 | 32 | 31527615 | |
| Pubmed | USP34 BCOR FAM53C SGPL1 NAF1 USP7 HELZ ASCC3 ANKRD52 WDR62 WDR48 EP400 P3H3 FAT3 ZNF629 FBRSL1 INO80 SP110 TAF6L MLH3 EAF1 TBK1 MEPCE WDFY3 KAT6B PRDM16 HDAC2 | 1.20e-08 | 1116 | 235 | 27 | 31753913 | |
| Pubmed | USP34 DCHS2 CEP57L1 FAM53C MTMR10 SEPTIN2 STXBP1 NF2 NOMO2 PKD1 USP7 OSBPL8 ALDOA SULT4A1 MGAT5B ARHGAP21 VCPIP1 KPNB1 COG2 WARS1 NBEA MED13L IDS CASK TJP1 SEC23IP WDFY3 ECE2 | 5.74e-08 | 1285 | 235 | 28 | 35914814 | |
| Pubmed | USP34 BCOR PRDM2 BRCA2 ASCC3 ANKRD52 ARHGAP21 WDR62 VCPIP1 USP24 MBIP JMJD1C TBK1 SEC23IP HDAC2 | 1.99e-07 | 418 | 235 | 15 | 34709266 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 36011023 | ||
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 37432648 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 3.05e-07 | 3 | 235 | 3 | 25576386 | |
| Pubmed | UBE2L6 WWC3 NDUFS3 NF2 USP7 GNA11 ASCC3 ALDOA CAMSAP2 KPNB1 VPS18 FARSB UPF1 MED13L RFX7 SERPINH1 CYFIP2 LIG3 EAF1 TJP1 SLC25A1 TBK1 MEPCE AQR HDAC2 HDLBP | 4.10e-07 | 1247 | 235 | 26 | 27684187 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | USP34 RBM12B BCOR USP7 DTX2 NUP160 STXBP5 RFX7 JMJD1C USP6NL | 4.59e-07 | 180 | 235 | 10 | 35198878 |
| Pubmed | USP34 NOL10 WDR75 USP7 OSBPL8 HELZ ASCC3 ANKRD52 NUP160 KPNB1 WARS1 USP24 UPF1 SERPINH1 TJP1 AQR HDAC2 HDLBP | 5.84e-07 | 653 | 235 | 18 | 22586326 | |
| Pubmed | USP34 SMG1 HDGFL1 NOL10 DCANP1 KCNQ3 ASCC3 MGAT5B RHOF PLK3 PADI1 WDR24 POMT2 VPS18 IBSP XDH NBEA CDH22 HHAT HBQ1 | 1.15e-06 | 832 | 235 | 20 | 36724073 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 1.21e-06 | 4 | 235 | 3 | 31833031 | |
| Pubmed | 1.21e-06 | 4 | 235 | 3 | 9267806 | ||
| Pubmed | BCOR NF2 USP7 ASCC3 VCPIP1 KPNB1 EP400 USP24 UPF1 MBIP JMJD1C TJP1 SLC25A1 SEC23IP HDAC2 HDLBP | 1.23e-06 | 549 | 235 | 16 | 38280479 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | AFTPH BCOR SEPTIN2 NAF1 USP7 HELZ ALDOA CAMSAP2 ARHGAP21 WDR62 VCPIP1 KPNB1 WARS1 EP400 FARSB UPF1 LIG3 TJP1 SEC23IP MEPCE HDLBP | 1.77e-06 | 934 | 235 | 21 | 33916271 |
| Pubmed | SMG1 BCOR STXBP1 WDR75 ANKRD52 MXRA5 POT1 USP24 FBRSL1 FARSB NBEA TEFM LIG3 SEC23IP UQCRQ WDFY3 NOMO3 | 1.92e-06 | 638 | 235 | 17 | 31182584 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ANKLE2 ERLEC1 NDUFS3 P3H1 OSBPL8 SAMM50 ASCC3 VCPIP1 KPNB1 USP24 FARSB UPF1 SERPINH1 ABCB10 SLC25A1 EXD2 TBK1 SEC23IP UQCRQ NOMO3 HDLBP | 2.02e-06 | 942 | 235 | 21 | 31073040 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | USP34 GALC ANKLE2 NDUFS3 NOMO2 P3H1 SGPL1 ALDOA VCPIP1 KPNB1 POMT2 P3H3 COX7C LAMA5 ADAMTS5 SERPINH1 CYFIP2 NOMO1 PARP10 TJP1 MEPCE UQCRQ PNPLA7 ENG USP6NL NOMO3 HDLBP | 2.13e-06 | 1451 | 235 | 27 | 30550785 |
| Pubmed | SMG1 ANKLE2 MTMR10 TBC1D1 PKD1 ASCC3 VCPIP1 KPNB1 LAMA5 NOMO1 CASK RNF14 TENM3 KIF13A NOMO3 HDLBP | 3.16e-06 | 591 | 235 | 16 | 15231748 | |
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 3.16e-06 | 92 | 235 | 7 | 10493829 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | P3H1 USP7 ALDH1A1 ASCC3 FARSB SERPINH1 LIG3 TJP1 SLC25A1 SCARB2 | 3.59e-06 | 226 | 235 | 10 | 37839992 |
| Pubmed | ERLEC1 SGPL1 USP7 OSBPL8 SAMM50 CAMSAP2 ANKRD52 USP24 COX7C KCTD17 NOMO1 LIG3 SEC23IP HLTF UQCRQ | 4.06e-06 | 533 | 235 | 15 | 25544563 | |
| Pubmed | WDR75 BRCA2 NOMO2 SAMM50 ANKRD52 ARHGAP21 MTARC1 WDR62 COG2 NOMO1 ABCB10 TBK1 SEC23IP HLTF INTS9 NOMO3 | 4.34e-06 | 606 | 235 | 16 | 36538041 | |
| Pubmed | SNPH PER2 TBC1D1 CAMSAP2 ARHGAP21 VCPIP1 WDR48 EP400 STXBP5 MED13L TENM3 SELENOI AQR | 4.69e-06 | 407 | 235 | 13 | 12693553 | |
| Pubmed | SNPH NDUFS3 SEPTIN2 CDKL5 STXBP1 C12orf50 SGPL1 USP7 OSBPL8 KCNQ3 SAMM50 ALDOA CAMSAP2 ARHGAP21 KPNB1 VPS18 WARS1 FARSB NBEA UPF1 CYFIP2 CASK TJP1 UQCRQ ABLIM2 HDLBP | 5.10e-06 | 1431 | 235 | 26 | 37142655 | |
| Pubmed | 6.72e-06 | 103 | 235 | 7 | 10819331 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 SPPL2B PER2 SSH1 NF2 PKD1 USP7 DTX2 RHOF PLK3 ARHGAP21 WDR24 EP400 FBRSL1 LAMA5 INO80 MED13L CCNE1 TRIB3 WDFY3 PRDM16 TRIB1 | 6.96e-06 | 1105 | 235 | 22 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AFTPH MAP3K20 FAM53C TBC1D1 OSBPL8 HELZ CAMSAP2 ARHGAP21 WDR62 VCPIP1 ZNF629 RFX7 SERPINH1 TJP1 SLC25A1 MEPCE KIF13A USP6NL AQR | 7.28e-06 | 861 | 235 | 19 | 36931259 |
| Pubmed | NDUFS3 WDR75 NOMO2 SGPL1 OSBPL8 NUP160 KPNB1 COG2 CASK ABCB10 SCARB2 SEC23IP HLTF AQR HDAC2 | 7.33e-06 | 560 | 235 | 15 | 35241646 | |
| Pubmed | 7.67e-06 | 147 | 235 | 8 | 29576527 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SMG1 NOMO2 P3H1 SGPL1 GNA11 NUP160 ARHGAP21 TMEM248 STXBP5 UPF1 ORMDL1 ABCB10 TENM3 SEC23IP GALNT5 KIF13A USP6NL | 9.25e-06 | 719 | 235 | 17 | 35337019 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | GALC AHI1 ANKLE2 FAM53C TBC1D1 NAF1 PTPRQ HELZ SAMM50 CAMSAP2 NUP160 MTARC1 WDR62 WDR24 KPNB1 WDR48 TEFM NOMO1 TAF6L IFT52 EAF1 TBK1 SEC23IP HDAC2 | 1.20e-05 | 1321 | 235 | 24 | 27173435 |
| Pubmed | PDPK1 ANKLE2 NDUFS3 SGPL1 SAMM50 ANKRD52 MTARC1 WDR62 VPS18 UPF1 TEFM RNF14 EXD2 TBK1 | 1.26e-05 | 515 | 235 | 14 | 31617661 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 BCOR BRCA2 NOMO2 USP7 HELZ ANKRD52 VCPIP1 EP400 ZNF629 FBRSL1 COX7C SERPINH1 TBK1 HDLBP | 1.30e-05 | 588 | 235 | 15 | 38580884 |
| Pubmed | Usp12 stabilizes the T-cell receptor complex at the cell surface during signaling. | 1.35e-05 | 22 | 235 | 4 | 26811477 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.66e-05 | 8 | 235 | 3 | 15257293 | |
| Pubmed | USP34 AHI1 CEP57L1 SPPL2B BCOR ANKLE2 PRDM2 RPS6KC1 WDR75 NF2 SGPL1 GNA11 DTX2 ARHGAP21 SCRN3 WARS1 TMEM248 FARSB INO80 IFT52 KIF13A | 1.70e-05 | 1084 | 235 | 21 | 11544199 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAP3K20 NOL10 NDUFS3 WDR75 SGPL1 A2ML1 USP7 SAMM50 ASCC3 ALDOA ANKRD52 NUP160 KPNB1 WARS1 EP400 FARSB UPF1 SERPINH1 LIG3 SLC25A1 HLTF WDFY3 AQR HDLBP | 1.78e-05 | 1353 | 235 | 24 | 29467282 |
| Pubmed | 1.94e-05 | 24 | 235 | 4 | 33722704 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CETP ENPP3 ACE FAH STXBP1 P3H1 PKD1 GNA11 SAMM50 ALDH1A1 ALDOA RHOF KPNB1 COL6A3 MXRA5 LAMA5 TECTA CYFIP2 SLC25A1 SCARB2 | 2.17e-05 | 1016 | 235 | 20 | 19056867 |
| Pubmed | Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. | 2.21e-05 | 170 | 235 | 8 | 19064572 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | AFTPH PDPK1 BCOR FAM53C PRDM2 SSH1 NAF1 USP7 HELZ CDT1 WDR62 VCPIP1 EP400 USP24 RFX7 KAT6B HDLBP | 2.37e-05 | 774 | 235 | 17 | 15302935 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | SNPH F5 RPS6KC1 SEPTIN2 NF2 SGPL1 A2ML1 USP24 FARSB UPF1 INO80 CASK HDLBP | 2.40e-05 | 475 | 235 | 13 | 31040226 |
| Pubmed | 2.47e-05 | 225 | 235 | 9 | 12168954 | ||
| Pubmed | 2.48e-05 | 9 | 235 | 3 | 16420563 | ||
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 2.48e-05 | 9 | 235 | 3 | 36261522 | |
| Pubmed | Brca2 is required for embryonic cellular proliferation in the mouse. | 2.48e-05 | 9 | 235 | 3 | 9171369 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 GALNS ERLEC1 NOMO2 P3H1 SGPL1 ARHGAP21 MTARC1 WDR62 POMT2 COL12A1 WARS1 TMEM248 P3H3 LAMA5 SERPINH1 NOMO1 TENM3 SCARB2 SELENOI ENG GALNT4 | 2.50e-05 | 1201 | 235 | 22 | 35696571 |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.67e-05 | 86 | 235 | 6 | 28327460 | |
| Pubmed | Proteomic analysis of the mouse liver mitochondrial inner membrane. | 2.72e-05 | 175 | 235 | 8 | 12865426 | |
| Pubmed | USP7 GNA11 ASCC3 ALDOA NUP160 KPNB1 FARSB UPF1 SERPINH1 CASK SLC25A1 SCARB2 SEC23IP | 2.92e-05 | 484 | 235 | 13 | 31995728 | |
| Pubmed | 2.95e-05 | 177 | 235 | 8 | 26206133 | ||
| Pubmed | ANKLE2 STXBP1 NF2 OSBPL8 ARHGAP21 WDR48 CYFIP2 NOMO1 CASK TENM3 SEC23IP USP6NL | 3.34e-05 | 421 | 235 | 12 | 36976175 | |
| Pubmed | Genetic predisposition to thrombophilia in inflammatory bowel disease. | 3.53e-05 | 10 | 235 | 3 | 20717043 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | USP34 NDUFS3 SEPTIN2 NOMO2 A2ML1 USP7 ANKRD52 NUP160 VCPIP1 KPNB1 WDR48 FARSB KCTD17 HDAC2 | 3.90e-05 | 571 | 235 | 14 | 37167062 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SMG1 RBM12B MAP3K20 NOL10 WDR75 NAF1 HELZ ASCC3 ALDOA KPNB1 FBRSL1 UPF1 TEFM MEPCE AQR HDAC2 HDLBP | 3.98e-05 | 807 | 235 | 17 | 22681889 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CHL1 GALNS CETP ACE FAH PYGM GNA11 ALDH1A1 ALDOA RHOF KPNB1 COL6A3 WARS1 CILP LAMA5 SI VWA1 CYFIP2 SCARB2 HBZ | 4.47e-05 | 1070 | 235 | 20 | 23533145 |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 11122103 | ||
| Pubmed | Sex-specific regulation of follicle-stimulating hormone secretion by synaptotagmin 9. | 4.55e-05 | 2 | 235 | 2 | 26482442 | |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 11596779 | ||
| Pubmed | Synaptotagmin IX regulates Ca2+-dependent secretion in PC12 cells. | 4.55e-05 | 2 | 235 | 2 | 11751925 | |
| Pubmed | ALDH1A1 and HLTF modulate the activity of lysosomal autophagy inhibitors in cancer cells. | 4.55e-05 | 2 | 235 | 2 | 28981387 | |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 26606397 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 21085706 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 23960081 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 21185205 | ||
| Pubmed | Ganglioside GD3 biosynthesis in normal and mutant mouse embryos. | 4.55e-05 | 2 | 235 | 2 | 1820026 | |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 36334706 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 20853144 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 11331269 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 11311153 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 22274752 | ||
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 4.83e-05 | 11 | 235 | 3 | 32820719 | |
| Pubmed | RBM12B F5 SEPTIN2 WDR75 NF2 P3H1 USP7 GNA11 NUP160 UPF1 CASK LIG3 TJP1 USP6NL HDAC2 | 4.90e-05 | 660 | 235 | 15 | 32780723 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RBM12B MAP3K20 NOL10 F5 SEPTIN2 WDR75 SGPL1 USP7 SAMM50 ASCC3 ALDOA NUP160 KPNB1 DDX60 FARSB UPF1 SERPINH1 TJP1 SLC25A1 MEPCE AQR HDLBP | 4.92e-05 | 1257 | 235 | 22 | 36526897 |
| Pubmed | RBM12B BCOR SAMM50 ARHGAP21 FBRSL1 JMJD1C PARP10 TENM3 TJP1 KAT6B GALNT4 | 5.00e-05 | 371 | 235 | 11 | 15747579 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | USP34 SMG1 PDPK1 MAP3K20 NOMO2 USP7 OSBPL8 ARHGAP21 VPS18 FBRSL1 SERPINH1 CYFIP2 NOMO1 CCNE1 CCNH TBK1 NOMO3 HDAC2 | 5.31e-05 | 910 | 235 | 18 | 36736316 |
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 5.54e-05 | 31 | 235 | 4 | 19136429 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | WDR75 NF2 P3H1 NAF1 USP7 ASCC3 ALDOA ANKRD52 NUP160 WDR24 VCPIP1 WDR48 CASK TAF6L TJP1 TBK1 MEPCE HLTF AQR | 6.00e-05 | 1005 | 235 | 19 | 19615732 |
| Pubmed | 6.41e-05 | 12 | 235 | 3 | 19008959 | ||
| Pubmed | USP34 BRCA2 RHOF EP400 POT1 MED13L SP110 JMJD1C TAF6L LIG3 SLC25A1 INTS9 | 6.74e-05 | 453 | 235 | 12 | 29656893 | |
| Pubmed | 6.89e-05 | 63 | 235 | 5 | 31266804 | ||
| Pubmed | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | PRDM2 NAF1 NUP160 VPS18 POT1 UPF1 TAF6L CCNH PARP10 TRIB3 TBK1 SELENOI | 7.33e-05 | 457 | 235 | 12 | 32968282 |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | WDR75 HELZ SAMM50 ASCC3 WARS1 FBRSL1 UPF1 SERPINH1 SLC25A1 TBK1 | 7.50e-05 | 322 | 235 | 10 | 39098523 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | AFTPH ACE ANKLE2 BRCA2 NOMO2 TBC1D1 GNA11 CAMSAP2 ANKRD52 ARHGAP21 WDR62 VCPIP1 KPNB1 STXBP5 PHAF1 TJP1 TBK1 | 7.84e-05 | 853 | 235 | 17 | 28718761 |
| Pubmed | ANKLE2 HELZ ARHGAP21 VCPIP1 SERPINH1 JMJD1C TJP1 SEC23IP USP6NL | 8.25e-05 | 263 | 235 | 9 | 34702444 | |
| Pubmed | Expression patterns of sulfatase genes in the developing mouse embryo. | 8.29e-05 | 13 | 235 | 3 | 20503373 | |
| Pubmed | Genetic influences on blood pressure within the Stanislas Cohort. | 8.29e-05 | 13 | 235 | 3 | 15076187 | |
| Pubmed | USP34 BCOR NDUFS3 P3H1 USP7 KPNB1 EP400 UPF1 INO80 SERPINH1 HLTF | 8.93e-05 | 396 | 235 | 11 | 26687479 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 9.18e-05 | 208 | 235 | 8 | 33230847 | |
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 1.01e-04 | 36 | 235 | 4 | 25615642 | |
| Pubmed | 1.14e-04 | 339 | 235 | 10 | 30415952 | ||
| Pubmed | SEPTIN2 WDR75 USP7 SAMM50 ASCC3 ALDOA NUP160 KPNB1 USP24 UPF1 SERPINH1 NOMO1 SEC23IP HDAC2 | 1.26e-04 | 638 | 235 | 14 | 33239621 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.29e-04 | 344 | 235 | 10 | 30333137 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | NDUFS3 USP7 HELZ KPNB1 USP24 SERPINH1 ABCB10 SLC25A1 EXD2 HDAC2 | 1.29e-04 | 344 | 235 | 10 | 36282215 |
| Pubmed | 1.30e-04 | 114 | 235 | 6 | 21150319 | ||
| Pubmed | 1.31e-04 | 15 | 235 | 3 | 11341749 | ||
| Pubmed | 1.36e-04 | 3 | 235 | 2 | 36732068 | ||
| Pubmed | APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease. | 1.36e-04 | 3 | 235 | 2 | 15106838 | |
| Pubmed | Methylation of PRDM2, PRDM5 and PRDM16 genes in lung cancer cells. | 1.36e-04 | 3 | 235 | 2 | 24966940 | |
| GeneFamily | UPF1 like RNA helicases | 1.01e-04 | 11 | 157 | 3 | 1169 | |
| GeneFamily | Sulfatases | 4.76e-04 | 18 | 157 | 3 | 410 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 6.57e-04 | 20 | 157 | 3 | 433 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | USP34 TRANK1 STXBP1 SULT4A1 RHOF STXBP5 IDS CYFIP2 RNF14 EFNA3 | 8.19e-08 | 194 | 233 | 10 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-07 | 199 | 233 | 10 | 92778939e9d06599c7d06cfd8f4362b97ed0606b | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.04e-07 | 199 | 233 | 10 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | C1QL1 COL6A3 MXRA5 COL12A1 CILP FAT3 SERPINH1 TENM3 SERPINA9 | 4.98e-07 | 181 | 233 | 9 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 6.55e-07 | 187 | 233 | 9 | 3c10b8501226c69d71bcd99dc1c064a3c2154f87 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 1.01e-06 | 197 | 233 | 9 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | erythropoietic|World / Lineage and Cell class | 1.01e-06 | 197 | 233 | 9 | a52546cebc222050c970e04cec97e4f48ab8fe10 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-06 | 110 | 233 | 7 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.41e-06 | 171 | 233 | 8 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.86e-06 | 184 | 233 | 8 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.86e-06 | 184 | 233 | 8 | 238eba615b4e04967d44ac7858a6673bdd7f67e9 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.86e-06 | 188 | 233 | 8 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-06 | 192 | 233 | 8 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.58e-06 | 141 | 233 | 7 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.58e-06 | 141 | 233 | 7 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | erythropoietic-Polychromatic_Erythroblast|World / Lineage and Cell class | 9.65e-06 | 197 | 233 | 8 | 604fcbf47f073c2af344e1b16b615a78ef838dc9 | |
| ToppCell | erythropoietic-Basophilic_Erythroblast|World / Lineage and Cell class | 1.00e-05 | 198 | 233 | 8 | b3db4db02c0e659163cefb3d83f53e4940cc04bf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 198 | 233 | 8 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 142 | 233 | 7 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.08e-05 | 200 | 233 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.08e-05 | 200 | 233 | 8 | d02e256b5d65a5c982ba5696bc7e077281ca3e24 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-05 | 200 | 233 | 8 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.20e-05 | 146 | 233 | 7 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|Lung / Manually curated celltypes from each tissue | 1.50e-05 | 151 | 233 | 7 | 9bfb807e1180b31fa9a2c500ce993de9707c070f | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 1.56e-05 | 152 | 233 | 7 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.92e-05 | 157 | 233 | 7 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-05 | 162 | 233 | 7 | 860ebf2390b4ad86475ad54717cbefcf61cd3b2a | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-05 | 162 | 233 | 7 | 14e9f8aaba308619eb9da90796c336e76cedac1f | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-1|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.65e-05 | 165 | 233 | 7 | 2ca1154a8692af311d99a4d3aa2f2ac3d23a4310 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-05 | 166 | 233 | 7 | 49103b75c3e08656c5774f56fd00d7bd53eefcfb | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6-Gad2-Th.Crhbp_(Supramammillary_Nucleus_(SuM)_Dopaminergic?,_Th+/Ddc+)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.06e-05 | 69 | 233 | 5 | f9c1b871e594e57f0d6da3754f76ee41189f4633 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6-Gad2-Th.Crhbp_(Supramammillary_Nucleus_(SuM)_Dopaminergic?,_Th+/Ddc+)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.06e-05 | 69 | 233 | 5 | 57df6acddf5fe7a1d6bc551c3e3de44102f2f1db | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6-Gad2-Th.Crhbp_(Supramammillary_Nucleus_(SuM)_Dopaminergic?,_Th+/Ddc+)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.06e-05 | 69 | 233 | 5 | ee2c7b86ef336c7d0c82a8950bf64457f2683732 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.09e-05 | 169 | 233 | 7 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.09e-05 | 169 | 233 | 7 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-05 | 169 | 233 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.09e-05 | 169 | 233 | 7 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.21e-05 | 170 | 233 | 7 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 3.21e-05 | 170 | 233 | 7 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-05 | 170 | 233 | 7 | b1a16600754e0c12f7d39c9221f1b03135833f16 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 172 | 233 | 7 | 6c17a1e586a72d1bd80c20c06370429c61dc9f85 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-05 | 176 | 233 | 7 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-05 | 176 | 233 | 7 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | NS-critical-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.00e-05 | 176 | 233 | 7 | 7cf1a06ceee1ec06532f44c729c31b4d58e5ea49 | |
| ToppCell | droplet-Marrow-nan-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-05 | 176 | 233 | 7 | f92063b72ebfeb9b192281dc63d6bf2759c78554 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 177 | 233 | 7 | 650095a17e1a39caea74a6e89646565b9332af5d | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 177 | 233 | 7 | d1af0cb4b1fb03f04cff5add85e29be8fb8f4dcb | |
| ToppCell | BAL-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 4.15e-05 | 177 | 233 | 7 | aa021f6d62e9d740c5ea499faaf875de835a2865 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.30e-05 | 178 | 233 | 7 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.45e-05 | 179 | 233 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | HSPCs-Erythroblasts|World / Lineage and Cell class | 4.78e-05 | 181 | 233 | 7 | ce26f1accc8f69b7bc4b929073e975c887566c6a | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 4.95e-05 | 182 | 233 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.95e-05 | 182 | 233 | 7 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.12e-05 | 183 | 233 | 7 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.30e-05 | 184 | 233 | 7 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 5.49e-05 | 185 | 233 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 186 | 233 | 7 | 6e6998f5ccb1b2628048a21e8d3053e020569aba | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.68e-05 | 186 | 233 | 7 | 24b23880d4ff8fb4a23e2012d5890b9e2fcf7283 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.87e-05 | 187 | 233 | 7 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.07e-05 | 188 | 233 | 7 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.07e-05 | 188 | 233 | 7 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.07e-05 | 188 | 233 | 7 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.07e-05 | 188 | 233 | 7 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 6.07e-05 | 188 | 233 | 7 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.07e-05 | 188 | 233 | 7 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | MS-CD8-CD4_Treg|MS / Condition, Cell_class and T cell subcluster | 6.07e-05 | 188 | 233 | 7 | 2f0e2c7d79ee2d69a5d908c0247dc950c056c30a | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 6.28e-05 | 189 | 233 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.28e-05 | 189 | 233 | 7 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-05 | 189 | 233 | 7 | 16dfc37d8d390ed7f927bc844c47c9c5a89a0928 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-05 | 189 | 233 | 7 | 3ade3fa9369e85304b20d7233b581f18ad5ecc89 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.49e-05 | 190 | 233 | 7 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.71e-05 | 191 | 233 | 7 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.71e-05 | 191 | 233 | 7 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.71e-05 | 191 | 233 | 7 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.71e-05 | 191 | 233 | 7 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | MS-Treg-exh_CD4|MS / Condition, Cell_class and T cell subcluster | 6.93e-05 | 192 | 233 | 7 | c6722bf142c84ccedd99c1a3344085aecb4cbab4 | |
| ToppCell | CV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 6.93e-05 | 192 | 233 | 7 | 2a2052b44e8f679ef484f03ba4fb37b0ec841b88 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.16e-05 | 193 | 233 | 7 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.16e-05 | 193 | 233 | 7 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.16e-05 | 193 | 233 | 7 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.16e-05 | 193 | 233 | 7 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.40e-05 | 194 | 233 | 7 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 195 | 233 | 7 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 195 | 233 | 7 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 195 | 233 | 7 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.89e-05 | 196 | 233 | 7 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 7.89e-05 | 196 | 233 | 7 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Erythrocytic_early|bone_marrow / Manually curated celltypes from each tissue | 7.89e-05 | 196 | 233 | 7 | 507254c4c00e535fe01851431b5b74a5f15d9592 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.14e-05 | 197 | 233 | 7 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.14e-05 | 197 | 233 | 7 | 99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3 | |
| ToppCell | CD8+_Memory_T_cell-CV-1|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.14e-05 | 197 | 233 | 7 | e59b47bccc781b2117196fe322efa87559c237c6 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.14e-05 | 197 | 233 | 7 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.40e-05 | 198 | 233 | 7 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.40e-05 | 198 | 233 | 7 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.40e-05 | 198 | 233 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | CV-Severe-1|CV / Virus stimulation, Condition and Cluster | 8.40e-05 | 198 | 233 | 7 | fc0e885e370ffb780eada62bb2b52065c2f8b26b | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 8.40e-05 | 198 | 233 | 7 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.40e-05 | 198 | 233 | 7 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 8.40e-05 | 198 | 233 | 7 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.40e-05 | 198 | 233 | 7 | 6e6af8fad09f8e48b3f2ce463d5773b6a69864d1 | |
| Disease | Glycogen Storage Disease Type V | 6.00e-05 | 2 | 229 | 2 | C0017924 | |
| Disease | white wine liking measurement | 6.00e-05 | 2 | 229 | 2 | EFO_0006948 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.76e-04 | 67 | 229 | 5 | EFO_0004286, EFO_0004623 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.40e-04 | 16 | 229 | 3 | C0393706 | |
| Disease | renal fibrosis (implicated_via_orthology) | 2.89e-04 | 17 | 229 | 3 | DOID:0050855 (implicated_via_orthology) | |
| Disease | lymphocyte measurement | 3.12e-04 | 117 | 229 | 6 | EFO_0803546 | |
| Disease | chronic lymphocytic leukemia | 3.42e-04 | 119 | 229 | 6 | EFO_0000095 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 3.56e-04 | 4 | 229 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 3.56e-04 | 4 | 229 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | bronchiolitis obliterans (implicated_via_orthology) | 3.56e-04 | 4 | 229 | 2 | DOID:2799 (implicated_via_orthology) | |
| Disease | Ullrich congenital muscular dystrophy | 3.56e-04 | 4 | 229 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 3.56e-04 | 4 | 229 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 3.56e-04 | 4 | 229 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 3.56e-04 | 4 | 229 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | Malignant neoplasm of kidney | 4.10e-04 | 45 | 229 | 4 | C0740457 | |
| Disease | Colorectal Carcinoma | CHL1 GALNS SYT9 ZNF232 F5 CDKL5 CAMSAP2 IQUB DNAH3 NPBWR2 VPS18 LIG3 CDH22 MLH3 ABCB10 | 4.21e-04 | 702 | 229 | 15 | C0009402 |
| Disease | esterified cholesterol measurement | 5.05e-04 | 128 | 229 | 6 | EFO_0008589 | |
| Disease | cholestasis (biomarker_via_orthology) | 5.69e-04 | 49 | 229 | 4 | DOID:13580 (biomarker_via_orthology) | |
| Disease | non-arteritic anterior ischemic optic neuropathy (is_implicated_in) | 5.91e-04 | 5 | 229 | 2 | DOID:0050864 (is_implicated_in) | |
| Disease | Gaucher Disease, Type 1 | 5.91e-04 | 5 | 229 | 2 | C1961835 | |
| Disease | Rett Syndrome, Atypical | 5.91e-04 | 5 | 229 | 2 | C2748910 | |
| Disease | intermediate density lipoprotein measurement | 5.94e-04 | 87 | 229 | 5 | EFO_0008595 | |
| Disease | melanoma | 7.50e-04 | 248 | 229 | 8 | C0025202 | |
| Disease | Malignant neoplasm of breast | CYP2D6 PDPK1 GALNT16 NDUFS3 PER2 NF2 BRCA2 ALDOA WARS1 IBSP XDH TECTA SP110 CCNE1 CCNH ABCB10 GALNT5 KAT6B HDLBP | 7.68e-04 | 1074 | 229 | 19 | C0006142 |
| Disease | Neurodevelopmental Disorders | 8.04e-04 | 93 | 229 | 5 | C1535926 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 8.28e-04 | 24 | 229 | 3 | DOID:1184 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.61e-04 | 195 | 229 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | uric acid measurement | USP34 HMGCS2 F5 PYGM TBXT ANKRD52 DNAH3 FAT3 FBRSL1 EFNA3 NR5A2 TRIB1 MAJIN | 1.04e-03 | 610 | 229 | 13 | EFO_0004761 |
| Disease | total lipids in IDL | 1.23e-03 | 60 | 229 | 4 | EFO_0022161 | |
| Disease | Cerebellar Diseases | 1.23e-03 | 7 | 229 | 2 | C0007760 | |
| Disease | Bilateral Wilms Tumor | 1.45e-03 | 29 | 229 | 3 | C2930471 | |
| Disease | C-C motif chemokine 5 measurement | 1.63e-03 | 8 | 229 | 2 | EFO_0008053 | |
| Disease | putamen volume | 1.77e-03 | 31 | 229 | 3 | EFO_0006932 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.81e-03 | 222 | 229 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | free cholesterol measurement | 1.92e-03 | 113 | 229 | 5 | EFO_0008591 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.96e-03 | 225 | 229 | 7 | EFO_0008317, EFO_0020947 | |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 1.99e-03 | 114 | 229 | 5 | EFO_0004529, EFO_0004611 | |
| Disease | Prostate cancer, familial | 2.06e-03 | 69 | 229 | 4 | C2931456 | |
| Disease | cholestasis (implicated_via_orthology) | 2.08e-03 | 9 | 229 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | colorectal adenoma | 2.12e-03 | 33 | 229 | 3 | EFO_0005406 | |
| Disease | Nonalcoholic Steatohepatitis | 2.17e-03 | 70 | 229 | 4 | C3241937 | |
| Disease | Non-alcoholic Fatty Liver Disease | 2.17e-03 | 70 | 229 | 4 | C0400966 | |
| Disease | ferritin measurement | 2.40e-03 | 119 | 229 | 5 | EFO_0004459 | |
| Disease | age at menarche | USP34 RBM12B PRDM2 RPS6KC1 ASCC3 FBRSL1 INO80 CYFIP2 SEC23IP CFAP61 ECE2 JHY | 2.49e-03 | 594 | 229 | 12 | EFO_0004703 |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 2.49e-03 | 120 | 229 | 5 | EFO_0004611, EFO_0004639 | |
| Disease | fetuin-B measurement | 2.59e-03 | 10 | 229 | 2 | EFO_0008128 | |
| Disease | heparin-binding egf-like growth factor measurement | 2.59e-03 | 10 | 229 | 2 | EFO_0020438 | |
| Disease | Nephroblastoma | 2.73e-03 | 36 | 229 | 3 | C0027708 | |
| Disease | psychosocial stress measurement | 3.15e-03 | 11 | 229 | 2 | EFO_0006783 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 3.15e-03 | 11 | 229 | 2 | C0268362 | |
| Disease | citrate measurement | 3.37e-03 | 79 | 229 | 4 | EFO_0010114 | |
| Disease | alcohol drinking | 3.69e-03 | 81 | 229 | 4 | EFO_0004329 | |
| Disease | Kidney Neoplasm | 3.69e-03 | 40 | 229 | 3 | C0022665 | |
| Disease | peptic esophagitis (biomarker_via_orthology) | 3.76e-03 | 12 | 229 | 2 | DOID:13976 (biomarker_via_orthology) | |
| Disease | integral membrane protein 2B measurement | 3.76e-03 | 12 | 229 | 2 | EFO_0802634 | |
| Disease | intracranial aneurysm (is_implicated_in) | 3.76e-03 | 12 | 229 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | liver cirrhosis (is_marker_for) | 3.85e-03 | 82 | 229 | 4 | DOID:5082 (is_marker_for) | |
| Disease | kidney disease (implicated_via_orthology) | 3.96e-03 | 41 | 229 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 4.40e-03 | 137 | 229 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 4.42e-03 | 13 | 229 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | X-11444 measurement | 4.42e-03 | 13 | 229 | 2 | EFO_0021237 | |
| Disease | liver fat measurement | 4.53e-03 | 43 | 229 | 3 | EFO_0010821 | |
| Disease | liver cirrhosis (is_implicated_in) | 4.53e-03 | 43 | 229 | 3 | DOID:5082 (is_implicated_in) | |
| Disease | Profound Mental Retardation | 4.67e-03 | 139 | 229 | 5 | C0020796 | |
| Disease | Mental deficiency | 4.67e-03 | 139 | 229 | 5 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 4.67e-03 | 139 | 229 | 5 | C0025363 | |
| Disease | phospholipid measurement | 4.82e-03 | 140 | 229 | 5 | EFO_0004639 | |
| Disease | concentration of large LDL particles measurement | 4.83e-03 | 44 | 229 | 3 | EFO_0022160 | |
| Disease | grey matter volume measurement | 4.83e-03 | 44 | 229 | 3 | EFO_0005420 | |
| Disease | cholesterol in medium VLDL measurement | 4.83e-03 | 44 | 229 | 3 | EFO_0022225 | |
| Disease | extrinsic allergic alveolitis (is_marker_for) | 5.13e-03 | 14 | 229 | 2 | DOID:841 (is_marker_for) | |
| Disease | cholesterol to total lipids in large VLDL percentage | 5.15e-03 | 45 | 229 | 3 | EFO_0022236 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 5.48e-03 | 46 | 229 | 3 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | Hereditary hearing loss and deafness | 5.74e-03 | 146 | 229 | 5 | cv:C0236038 | |
| Disease | free cholesterol in small VLDL measurement | 5.82e-03 | 47 | 229 | 3 | EFO_0022272 | |
| Disease | free cholesterol in very small VLDL measurement | 5.82e-03 | 47 | 229 | 3 | EFO_0022275 | |
| Disease | phosphoglycerides measurement | 6.17e-03 | 48 | 229 | 3 | EFO_0022291 | |
| Disease | sphingomyelin measurement | 6.22e-03 | 278 | 229 | 7 | EFO_0010118 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 6.25e-03 | 94 | 229 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | platelet component distribution width | AHI1 TRANK1 USP7 SYT5 RHOF VPS18 DBF4B ZNF629 LAMA5 JMJD1C KCTD17 PRDM16 TRIB1 | 6.39e-03 | 755 | 229 | 13 | EFO_0007984 |
| Disease | breast cancer (is_implicated_in) | 6.42e-03 | 150 | 229 | 5 | DOID:1612 (is_implicated_in) | |
| Disease | cholesterol in small LDL measurement | 6.54e-03 | 49 | 229 | 3 | EFO_0022227 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 6.70e-03 | 16 | 229 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | endometriosis (biomarker_via_orthology) | 6.70e-03 | 16 | 229 | 2 | DOID:289 (biomarker_via_orthology) | |
| Disease | Blood Coagulation Disorders | 6.70e-03 | 16 | 229 | 2 | C0005779 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 6.70e-03 | 16 | 229 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 6.73e-03 | 96 | 229 | 4 | EFO_0004529, EFO_0008595 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 6.91e-03 | 50 | 229 | 3 | EFO_0010732 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 6.91e-03 | 50 | 229 | 3 | EFO_0022334 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 6.91e-03 | 50 | 229 | 3 | EFO_0022303 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 6.91e-03 | 50 | 229 | 3 | EFO_0022247 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 7.30e-03 | 51 | 229 | 3 | cv:CN043650 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 7.30e-03 | 51 | 229 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 7.30e-03 | 51 | 229 | 3 | EFO_0022242 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 7.49e-03 | 99 | 229 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 7.49e-03 | 99 | 229 | 4 | EFO_0004574, EFO_0008595 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 7.49e-03 | 99 | 229 | 4 | EFO_0004639, EFO_0008595 | |
| Disease | triglyceride measurement, alcohol drinking | 7.49e-03 | 99 | 229 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | Glycogen storage disease | 7.55e-03 | 17 | 229 | 2 | cv:C0017919 | |
| Disease | muscular dystrophy (is_implicated_in) | 7.55e-03 | 17 | 229 | 2 | DOID:9884 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AFSQKPAQSRKFYHP | 331 | F5H4B4 | |
| HPKYRFRASPVNDIF | 246 | Q96DZ1 | |
| FSAQPRRFEHGSPSY | 106 | Q96L91 | |
| VFAGFHYPQDLARPL | 636 | Q9HCM7 | |
| RFPPATENFLYHLAA | 336 | Q6NSW5 | |
| FRLYPFTVHTVSPGN | 136 | Q8TF63 | |
| RFKSQLPDLSGPHSY | 881 | Q86XL3 | |
| SHSPPGFKDYSEEFL | 1971 | Q96N23 | |
| EPFPASNYIRLFGQH | 1106 | Q8NHU2 | |
| LFPRPDQQHSVAYTF | 366 | P11597 | |
| RSHYEEGPGKNLPFS | 16 | P15954 | |
| HNPYRPFEGFLIDLK | 161 | P51946 | |
| FDPGAKFHIPSSVPY | 1111 | P12821 | |
| FRVLPHPSFVYTAKF | 691 | Q8N157 | |
| FKSPIRDISYHPFEN | 886 | Q8N157 | |
| DYTRPKEEFVPSNHF | 51 | Q6ULP2 | |
| ASHSPQRPLFLYVAF | 221 | Q5FYB1 | |
| HVYTREGFSFEALPP | 191 | Q9UNA0 | |
| NTKGHPFYRGNEDTP | 136 | Q9H2F3 | |
| HETLYQKADDGRPFP | 81 | P04075 | |
| YHPNFPFSGKIRVRG | 351 | A8K2U0 | |
| APFKLNLHPRDYFDA | 191 | A7E2U8 | |
| YPPKLHQFAYVTDGA | 206 | P24864 | |
| KAPAYQRFHALAQPG | 166 | Q9H211 | |
| TVPRVAFYAGLKNPH | 126 | O75973 | |
| ALEFKNVHFAYPARP | 491 | Q9NRK6 | |
| PIDGNFFTYTRHEPI | 146 | P00352 | |
| DSFHSRFPYSKSDPL | 501 | Q6H8Q1 | |
| HEYFANAPQPIFKGR | 971 | O60306 | |
| LEHSPFSYLEGNPFT | 811 | Q8NB46 | |
| EYSVGNKHRDPFEAP | 1081 | Q6W2J9 | |
| FPSIKSRSHLPAVFY | 61 | Q2M2E5 | |
| PRASFHTIRYDFKPA | 26 | Q96JC9 | |
| GDPRFSFLLHFYTVP | 526 | P17813 | |
| VFRKRHPYNFPEGNA | 346 | Q8N428 | |
| PPIYSVGAFENFRHQ | 516 | Q8IXT5 | |
| LFFHFPPLLRDGENY | 1096 | P69849 | |
| FGYIEAPHKSFPVVF | 356 | Q9ULC6 | |
| PFEQRAYPHVFTKGI | 21 | O14949 | |
| YPSIHGDFSNDFRQP | 376 | Q9NV88 | |
| FGDSFTPYFPRVLKQ | 56 | P0C1H6 | |
| EPNYPKSIHSFGFPN | 361 | P39900 | |
| SREKPFEDFLPSHYN | 291 | Q32P28 | |
| RGQTSPHTPNEKFYG | 501 | Q32P28 | |
| TQAYFSPERPLHLSF | 546 | Q8IVL6 | |
| PFAPDYIQRSLFHRK | 866 | Q9ULG1 | |
| GFSEPYLQFQDPTKH | 666 | Q9Y5F3 | |
| GHYPQPSATFSLAKL | 1806 | Q8WYB5 | |
| AVSSHKFNSFYGDPP | 311 | O14936 | |
| LFFHFPPLLRDGENY | 1096 | Q5JPE7 | |
| DFSYVHKVPSFQPFV | 931 | Q71F56 | |
| FTYPFPETRFLHAGP | 6 | Q3KP22 | |
| PETRFLHAGPNVYKF | 11 | Q3KP22 | |
| SFLKSQPYRLVHFEP | 171 | Q5VT66 | |
| LSPNYEHGARRSKPF | 196 | Q6NUN7 | |
| KDGNPFYFTDHRIIP | 71 | O00533 | |
| HETAFLSPKRLFPYK | 46 | Q5TGJ6 | |
| TPHNTSKGFQRPVYL | 666 | Q7L2J0 | |
| LFHNPFYIGKSTPCI | 551 | Q9NXD2 | |
| LFRHSELFPPFAKGI | 71 | Q96S38 | |
| SVFGTHQAFAPYNKP | 236 | Q86UW9 | |
| PFATAGIFATYLPDH | 156 | A0A075B734 | |
| KGEEPAHSPVFCRFY | 1741 | Q15652 | |
| KFNLASHLPGFFVRP | 2296 | Q15652 | |
| KVSPYGFFAHDPVNL | 706 | O43525 | |
| PIHYAAAKGDFPSLR | 141 | B1AK53 | |
| GFVEYSHLLPPNSFE | 191 | Q9BQE6 | |
| VLAHLFGRRYFPPKF | 1486 | Q8IY21 | |
| APFYARNHPKALNFG | 626 | P0DPD6 | |
| HLLGYPFSRNSPGEK | 256 | Q9NVH0 | |
| QREQFYHKVNFSPPG | 466 | P54868 | |
| GKPTSREVFSQHPYA | 571 | Q3V5L5 | |
| VGVFHSFTSPYKLPL | 236 | O15055 | |
| TETEHSFKNYVRPGP | 621 | Q9UHC1 | |
| LFFHFPPLLRDGENY | 1096 | Q15155 | |
| LDLSKYRSFHFPAPD | 261 | Q8WX77 | |
| FAHPVFVDGDYPATL | 631 | P09848 | |
| HPPYFNLAEGARIAA | 46 | O15230 | |
| TRIPKFGRDFSYHYP | 131 | Q9BSC4 | |
| YSSYRNFVGPPHFKT | 926 | Q96F07 | |
| DHFSYFSRSLKPVLP | 521 | P49916 | |
| YVFLHAVKGTPFETP | 61 | Q9P0S3 | |
| QPAHKDFYPLTFFTA | 891 | P42694 | |
| THETAFLGPKDLFPY | 51 | Q9Y3E1 | |
| DPTYFGPILNFLRHG | 81 | Q8N5Z5 | |
| TGHNATFSEPLPFLY | 31 | P48146 | |
| LPAAAFHGVFEKYPE | 246 | Q6ZV29 | |
| PPHLQFNKFVLTGYR | 16 | Q8N4S7 | |
| PVTFHFLAKFYPENA | 91 | P35240 | |
| TFIYNSHPDKNFPAR | 531 | Q9UMZ3 | |
| FLSYEAPQAFRIDPH | 706 | Q6V1P9 | |
| PPISAFYVSNRKDGF | 516 | Q9BZF1 | |
| YPVLHNGPILSFSEF | 211 | Q5VTY9 | |
| TPPYAACLGFEFRKH | 306 | Q9BZG2 | |
| PELAKASGSPHAVYF | 831 | Q5K4E3 | |
| HPALSAFPSNIFYEG | 716 | Q92900 | |
| PARLFESSFHYFGPV | 166 | Q99999 | |
| HAPVYASKPFLGTSQ | 236 | P34059 | |
| ARHYPGDFSPALQAS | 111 | P09105 | |
| ERLFLSHPQTKTYFP | 31 | P02008 | |
| FPLNRPILAFYHSKN | 191 | Q9Y366 | |
| FRKFHYLPFVPSAED | 171 | P06340 | |
| PHSPIKFSEKFQRYS | 116 | P52797 | |
| FQIYQPREPLHFSKF | 3046 | P51587 | |
| PKPRFTYFPFSLGHR | 421 | Q9Y6A2 | |
| HAEGNPRQYKLFYAP | 1866 | Q99715 | |
| NFLPTPSKSHYVFNL | 2261 | Q8TD57 | |
| KNITHGFLYPPASNR | 686 | O14638 | |
| PGARKHPFSGKSFYL | 41 | Q8NFT6 | |
| HFVKPEAFLPFSAGR | 426 | P10635 | |
| GHVFPKRAPYARPNF | 361 | Q8N4A0 | |
| VGHIFRNDNPYSFPK | 721 | Q7Z7M9 | |
| SHLVDYFPEFDGPQR | 286 | P29992 | |
| DTVRPEFYFNTHPTK | 491 | P12111 | |
| ENLHTPYFPDFAVVG | 1036 | Q8TDW7 | |
| DYHVKFRNPPLVNGS | 201 | Q3MIR4 | |
| FGHYFNDTLVFLPPV | 296 | P0DN25 | |
| PLPRAHIKEYFYTSG | 41 | P13501 | |
| NITRDFFDPLYPGTK | 141 | P56746 | |
| PDFLSYRHASFGPRV | 556 | Q8IY82 | |
| YINLFHFPPLIKDSG | 411 | Q9NYL2 | |
| PGKFYRVSQSALNPH | 711 | Q9NYL2 | |
| FPYRPHSSLLDFLKG | 26 | Q96JA4 | |
| AEQGRPPEHTSKFYA | 301 | Q14974 | |
| RTDAIFTPYPGFKSH | 196 | Q9NS73 | |
| FTPYPGFKSHVKVSR | 201 | Q9NS73 | |
| TLFFHYIKTPLFNPE | 566 | Q8NA54 | |
| SHFQIYPFSLRKPNS | 371 | Q9C0D9 | |
| HPRAFTSYIKPTSFG | 666 | Q6UWL6 | |
| GSYHKPPERVFVPSF | 11 | Q8IYX8 | |
| GHRFYFRLVPEAPSN | 531 | Q9UJ99 | |
| DFPIHNLPYGVFSTR | 11 | P16930 | |
| ASPFFLAVGYHKPHI | 216 | P22304 | |
| VHGNFPRLSYPTFFP | 21 | Q14527 | |
| DNPPKFAQSLYHFSV | 271 | P55286 | |
| LFNPGNPDAFHEKYT | 331 | Q14746 | |
| NFPQFLHEGLSKPVY | 76 | Q5XKR9 | |
| EYFGPDFKLHISPSN | 336 | Q92769 | |
| NIHTPVSRPNRGFFY | 541 | P32298 | |
| DSGSPVFFYEFQHRP | 431 | Q6UWW8 | |
| KLFYSNPRFHGLRFP | 236 | O76039 | |
| HSKCIRPFLPYFNVS | 391 | P54803 | |
| RFPPATENFLYHLAA | 336 | Q8TCE6 | |
| HRPYSPPFFSLALAQ | 186 | Q9NYF3 | |
| SYGLSFFKPRPGNFE | 171 | Q9Y512 | |
| PIFTKVPRFNYVNHD | 606 | Q6ZTR5 | |
| PVLFYPSALGRADHQ | 2706 | Q6ZTR5 | |
| VPAIKPFDHYDFSRA | 16 | Q08AD1 | |
| DVRLGLNQHYPSFKP | 1286 | Q13029 | |
| ADHRPYTFFISPGSR | 2971 | P98161 | |
| RYSPPNADGHKAVFV | 931 | Q53GL7 | |
| SILPKEHGSQFFYLP | 1201 | Q9H1H9 | |
| YGHFPSRAIKSEYPD | 261 | O00482 | |
| PHFGETFAFKVPYVE | 171 | O00445 | |
| FPVPYNDLEARKLHF | 291 | Q86SS6 | |
| RIGYPKPALLHSTFF | 326 | P23381 | |
| VFQKSRFAPRGAPHF | 546 | Q9Y6J9 | |
| YNISVDPFPFEHFRG | 586 | O75445 | |
| QGSFPEHYAPSVFEK | 41 | Q9HBH0 | |
| DPLKPFGGYSRNVTH | 121 | Q9NWD8 | |
| YINRTFFFDVHPPLG | 96 | Q9UKY4 | |
| GHVKNFFNPPIISRF | 2186 | P12259 | |
| PHFLRESKSYFNPSN | 461 | Q86YW0 | |
| LQRNKFPGPSHTESY | 431 | Q587J7 | |
| IHFSFPASPKVFGGR | 751 | Q587J7 | |
| HFFTGTPDPERSVFK | 296 | Q0VDG4 | |
| EGYGPLKAHPFFESV | 331 | O15530 | |
| YGFEGHPFRKDFPLS | 191 | O75489 | |
| HPFRKDFPLSGYVEL | 196 | O75489 | |
| IPEQSFGHSFYKETP | 1631 | Q8NFP9 | |
| ASLGFNEYFPSRPHP | 481 | Q9HAZ2 | |
| LGSLPYHSAFPFQFL | 716 | Q9HAZ2 | |
| PNFPHSLYPFTDRAL | 731 | Q9HAZ2 | |
| ETYAPLFSLPSFHKF | 746 | Q96Q15 | |
| KRPPSAFFLFCSEYH | 96 | B2RPK0 | |
| GAPIIPRTSSKYFNF | 111 | Q9NUX5 | |
| LRSPKLFYADHPFIF | 376 | P50454 | |
| FYPHLKRFPVQGSSD | 51 | P21815 | |
| SLIHVFRPDISPYFG | 186 | Q14108 | |
| ADPRVFFPSDKIVHY | 311 | Q96QE5 | |
| RDQPPGYKLNSYGFH | 1136 | P14410 | |
| LPTCKGFFNIYHPLD | 811 | Q9Y6Y8 | |
| FGLGPRFPASNTYEK | 281 | O15079 | |
| LGIAYAIHKPFPFFE | 21 | Q9HB58 | |
| PSIFDSPYHLQGKRE | 86 | Q8TBB0 | |
| APKYEPNFAHGLASL | 146 | Q9BSU1 | |
| FKDPPTAKYRAAHVF | 91 | P61764 | |
| TVRHGFPYQPSALAF | 51 | Q5T5C0 | |
| HQYFGIEFPLSATAP | 1366 | Q12769 | |
| FPNGKSHTFPELAYR | 291 | Q9NSD9 | |
| FHPEYTRKNFPFLVG | 216 | Q86WD7 | |
| YPLEHPFDFRVKGVT | 331 | O95470 | |
| KSPPPFFYRLDHTSS | 896 | Q8WYL5 | |
| PFFFPTQGHDYVLAE | 746 | Q8N3C0 | |
| PPSAAHFRFYQIEGD | 906 | O75339 | |
| YNAFGKPFETLHGPL | 121 | P58418 | |
| KSGEYYRFHTPPDIL | 121 | Q8NA57 | |
| PKPLPSQFGHYFETT | 86 | Q9H5F2 | |
| RENSEKIHPYAFIPF | 431 | Q86W10 | |
| KIHPYAFIPFSAGLR | 436 | Q86W10 | |
| YIPPTHTFLAFAEKR | 31 | Q9UQ49 | |
| ELPFFHPSGKLEIYR | 796 | O75443 | |
| TKPRDPDNELYFAHG | 101 | Q63HM9 | |
| VHVGSRPYTEFPFGQ | 76 | Q6PCB0 | |
| HDFFTKGYTPDRLPI | 311 | Q9H4B4 | |
| SLSRANPYKHFNDPG | 436 | Q9UBS8 | |
| NKFTFKVQPPSHARY | 601 | Q92738 | |
| LPKYSAFQLAPFQDH | 761 | Q92738 | |
| PFYLQPHASSGAKTL | 566 | Q8TAF3 | |
| RYPFHDSDPSALFSK | 281 | Q96RU8 | |
| SFLPKHTNVPALYFL | 1761 | Q8IZQ1 | |
| EKARPEFTLPVHFYG | 191 | P11217 | |
| ESKYFEFHGVRLPPF | 16 | Q9BR01 | |
| QAFELRFKQYLHSPP | 296 | P98077 | |
| PTTPFYFILGKHRQQ | 691 | Q8IWA0 | |
| AGHYPFQDSEPVLLF | 256 | Q96RU7 | |
| SAVPYKFFPEPSGLH | 71 | O14813 | |
| LARHRDPQLFYKFSP | 586 | Q9P253 | |
| FGKCRIPNNSLPYFH | 276 | Q8TCT7 | |
| RFTVKPVVLGFPYFH | 331 | A6NK02 | |
| YHLKAFNLRISFPPE | 46 | O14933 | |
| DLGRTFPTHPYFSAQ | 851 | Q86TI0 | |
| IHDQTSPNPKYRGFF | 151 | P53007 | |
| SPNPKYRGFFHGVRE | 156 | P53007 | |
| PIKDQLGSSFYSHLP | 151 | Q8N4W9 | |
| TIKRDPPSYFFGTIH | 46 | Q86V40 | |
| YGRKGLPPSHTQYDF | 431 | Q9P273 | |
| DHTFFPGYRKTLLSP | 386 | P47989 | |
| LGAQFFRGSPAHYTP | 371 | O15178 | |
| RFRKPHAFAVPGQSY | 996 | Q2KHR2 | |
| TFPHLPGKTFVYNAS | 941 | Q96JH7 | |
| EPSFLFHRKAEAVYP | 346 | O43379 | |
| YFDRRSFENKPPAHI | 1361 | Q07157 | |
| FYSVPRTILPHGASF | 941 | Q9UPU5 | |
| QPFPKSEQVYLHFLS | 176 | Q9UNY5 | |
| PIKDQLGSSFYSHLP | 151 | Q8N823 | |
| YFISPFGHGLKPLDV | 151 | Q15019 | |
| VLSFDFPFYGHPLRQ | 136 | Q8IUK5 | |
| FPFYGHPLRQITIAT | 141 | Q8IUK5 | |
| KAFHPFIAGPYNRLV | 231 | Q00341 | |
| YGTPETLPFLIAHAF | 231 | Q70CQ2 | |
| AFKNLTPHASQYPGA | 2881 | Q70CQ2 | |
| HALYDSRLPPDFFGV | 621 | Q96S15 | |
| PFSGKTAYLFSPDHS | 1166 | Q9BXT5 | |
| KFTRGPENYFSPSKA | 2731 | O15050 | |
| QLTHGNEKPFLFPDY | 681 | Q9UEG4 | |
| GFTLRHFIVYPPESA | 61 | Q5T5U3 | |
| SNYDHFPKVPGGFSL | 646 | Q6BDS2 | |
| FKGHTLNFVAPFPLS | 711 | Q6BDS2 | |
| YPDRPHQKSVGFFLQ | 106 | Q93009 | |
| HPFAAQAGPYSPEKF | 846 | Q9ULE0 | |
| FYHAATGSLPFRPFE | 211 | Q9UHD2 | |
| PRNLIYFGEHPLSFA | 156 | Q9NQA5 | |
| VHGPLSSTPAFARYF | 701 | P23276 | |
| RIPHYSNGRLPFFTN | 1721 | Q9NR99 | |
| PVAHPFYVLRFNSSD | 246 | Q96HR8 | |
| NYRSELHIFPASPGA | 101 | Q8TDC0 |